Background Estimates of the case hospitalization rate and case fatality rate when hospital
care is available for monkeypox (MPX) infections have not been well defined. This rapid …

Since May 2022, large numbers of human mpox (previously known as monkeypox) cases
have been reported in non-endemic regions. We conducted a systematic review and meta …

Summary Background By October 30, 2022, 76,871 cases of mpox were reported
worldwide, with 20,614 cases in Latin America. This study reports characteristics of a case …

A 48-year-old man with poorly controlled HIV presented with severe human monkeypox
virus (hMPXV) infection, having completed 2 weeks of tecovirimat at another hospital. He …

During the COVID-19 pandemic, the increase in reports of human monkeypox virus infection
cases spreading in many countries outside Africa is a major cause for concern. Therefore …

Mpox (formerly Monkeypox), a neglected tropical disease once confined to Central and West
Africa, emerged as a global epidemic outbreak in May, 2022 with 87,529 cases reported as …

Until May 2022, zoonotic infectious disease monkeypox (MPX) caused by the monkeypox
virus (MPXV) was one of the forgotten viruses considered to be geographically limited in …

The rising global incidence of human Mpox cases necessitates prompt and accurate
identification for effective disease control. Previous studies have predominantly delved into …

Mpox, previously known as monkeypox, is caused by an Orthopoxvirus related to the variola
virus that causes smallpox. Prior to 2022, mpox was considered a zoonotic disease endemic …

Monkeypox is a zoonotic disease, endemic in central and west African regions, and has re‐
emerged, currently causing an outbreak as of May 2022. In this systematic review, we aimed …